156 related articles for article (PubMed ID: 20453222)
1. Flow cytometric analysis of peripheral blood and tumor-infiltrating regulatory T cells in dogs with oral malignant melanoma.
Tominaga M; Horiuchi Y; Ichikawa M; Yamashita M; Okano K; Jikumaru Y; Nariai Y; Kadosawa T
J Vet Diagn Invest; 2010 May; 22(3):438-41. PubMed ID: 20453222
[TBL] [Abstract][Full Text] [Related]
2. Relationship between regulatory and type 1 T cells in dogs with oral malignant melanoma.
Horiuchi Y; Tominaga M; Ichikawa M; Yamashita M; Okano K; Jikumaru Y; Nariai Y; Nakajima Y; Kuwabara M; Yukawa M
Microbiol Immunol; 2010 Mar; 54(3):152-9. PubMed ID: 20236425
[TBL] [Abstract][Full Text] [Related]
3. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer.
Biller BJ; Elmslie RE; Burnett RC; Avery AC; Dow SW
Vet Immunol Immunopathol; 2007 Mar; 116(1-2):69-78. PubMed ID: 17224188
[TBL] [Abstract][Full Text] [Related]
4. Association of tumour-infiltrating regulatory T cells with adverse outcomes in dogs with malignant tumours.
Sakai K; Maeda S; Yamada Y; Chambers JK; Uchida K; Nakayama H; Yonezawa T; Matsuki N
Vet Comp Oncol; 2018 Sep; 16(3):330-336. PubMed ID: 29322606
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of canine CD25 for validation of an anti-human CD25 antibody to compare T regulatory lymphocytes in healthy dogs and dogs with osteosarcoma.
Rissetto KC; Rindt H; Selting KA; Villamil JA; Henry CJ; Reinero CR
Vet Immunol Immunopathol; 2010 May; 135(1-2):137-145. PubMed ID: 20197202
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral T-Lymphocyte Subsets in Canine Oral Melanoma and Their Association With Clinical and Histopathological Parameters.
Yasumaru CC; Xavier JG; Strefezzi RF; Salles-Gomes COM
Vet Pathol; 2021 May; 58(3):491-502. PubMed ID: 33764216
[TBL] [Abstract][Full Text] [Related]
7. Generation of blood-derived dendritic cells in dogs with oral malignant melanoma.
Catchpole B; Stell AJ; Dobson JM
J Comp Pathol; 2002; 126(2-3):238-41. PubMed ID: 11945016
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow-derived dendritic cell vaccination of dogs with naturally occurring melanoma by using human gp100 antigen.
Gyorffy S; Rodriguez-Lecompte JC; Woods JP; Foley R; Kruth S; Liaw PC; Gauldie J
J Vet Intern Med; 2005; 19(1):56-63. PubMed ID: 15715049
[TBL] [Abstract][Full Text] [Related]
9. Tumour-infiltrating lymphocytes in canine melanocytic tumours: An investigation on the prognostic role of CD3
Porcellato I; Silvestri S; Menchetti L; Recupero F; Mechelli L; Sforna M; Iussich S; Bongiovanni L; Lepri E; Brachelente C
Vet Comp Oncol; 2020 Sep; 18(3):370-380. PubMed ID: 31750993
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
[TBL] [Abstract][Full Text] [Related]
11. Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma.
von Euler H; Sadeghi A; Carlsson B; Rivera P; Loskog A; Segall T; Korsgren O; Tötterman TH
J Immunother; 2008 May; 31(4):377-84. PubMed ID: 18391758
[TBL] [Abstract][Full Text] [Related]
12. Increased numbers of FoxP3-expressing CD4+ CD25+ regulatory T cells in peripheral blood from dogs with atopic dermatitis and its correlation with disease severity.
Hauck V; Hügli P; Meli ML; Rostaher A; Fischer N; Hofmann-Lehmann R; Favrot C
Vet Dermatol; 2016 Feb; 27(1):26-e9. PubMed ID: 26748886
[TBL] [Abstract][Full Text] [Related]
13. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
Hilchey SP; Bernstein SH
Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
[TBL] [Abstract][Full Text] [Related]
14. A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma.
Maekawa N; Konnai S; Takagi S; Kagawa Y; Okagawa T; Nishimori A; Ikebuchi R; Izumi Y; Deguchi T; Nakajima C; Kato Y; Yamamoto K; Uemura H; Suzuki Y; Murata S; Ohashi K
Sci Rep; 2017 Aug; 7(1):8951. PubMed ID: 28827658
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma.
Mougiakakos D; Johansson CC; Trocme E; All-Ericsson C; Economou MA; Larsson O; Seregard S; Kiessling R
Cancer; 2010 May; 116(9):2224-33. PubMed ID: 20209608
[TBL] [Abstract][Full Text] [Related]
16. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
[TBL] [Abstract][Full Text] [Related]
17. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
MacEwen EG; Kurzman ID; Vail DM; Dubielzig RR; Everlith K; Madewell BR; Rodriguez CO; Phillips B; Zwahlen CH; Obradovich J; Rosenthal RC; Fox LE; Rosenberg M; Henry C; Fidel J
Clin Cancer Res; 1999 Dec; 5(12):4249-58. PubMed ID: 10632367
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890
[TBL] [Abstract][Full Text] [Related]
20. T regulatory cells mediate immunosuppresion by adenosine in peripheral blood, sentinel lymph node and TILs from melanoma patients.
Di Gennaro P; Gerlini G; Caporale R; Sestini S; Brandani P; Urso C; Pimpinelli N; Borgognoni L
Cancer Lett; 2018 Mar; 417():124-130. PubMed ID: 29306022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]